Terns Pharmaceuticals Inc. (TERN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Terns Pharmaceuticals Inc...

    NASDAQ: TERN · Real-Time Price · USD
    7.17
    0.11 (1.56%)
    At close: Sep 05, 2025, 11:05 AM

    Terns Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 1M
    Cost of Revenue
    		 n/a 881K 1.03M 512K
    Gross Profit
    		 n/a -881K -1.03M 488K
    Operating Income
    		 -101.87M -102.56M -62.03M -49.86M
    Interest Income
    		 13.29M 12.9M 2.11M 170K
    Pretax Income
    		 -88.59M -89.97M -59.99M -49.65M
    Net Income
    		 -88.85M -90.21M -60.34M -50.16M
    Selling & General & Admin
    		 31.76M 39.06M 22.41M 19.55M
    Research & Development
    		 70.11M 63.5M 39.62M 31.31M
    Other Expenses
    		 n/a n/a -68K 40K
    Operating Expenses
    		 101.87M 102.56M 62.03M 50.86M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 102.56M 62.03M 50.86M
    Income Tax Expense
    		 260K 239K 358K 508K
    Shares Outstanding (Basic)
    		 79.51M 71.26M 36.03M 25.27M
    Shares Outstanding (Diluted)
    		 79.51M 71.26M 36.03M 25.27M
    EPS (Basic)
    		 -1.12 -1.27 -1.67 -1.98
    EPS (Diluted)
    		 -1.12 -1.27 -1.67 -1.98
    EBITDA
    		 -87.7M -102.27M -58.95M -49.35M
    EBIT
    		 -88.59M -102.56M -62.03M -49.86M
    Depreciation & Amortization
    		 896K 292K 1.03M 512K

    Add to Watchlist